Next earnings date: 27 Aug 2025

CLS Holdings USA, Inc. – OTC:CLSH
CLS Holdings USA stock price today
CLS Holdings USA stock price monthly change
CLS Holdings USA stock price quarterly change
CLS Holdings USA stock price yearly change
CLS Holdings USA key metrics
Market Cap | 4.55M |
Enterprise value | 15.87M |
P/E | -0.23 |
EV/Sales | 0.66 |
EV/EBITDA | -2.91 |
Price/Sales | 0.13 |
Price/Book | -0.38 |
PEG ratio | N/A |
EPS | -0.14 |
Revenue | 22.10M |
EBITDA | 585.25K |
Income | -10.45M |
Revenue Q/Q | N/A |
Revenue Y/Y | N/A |
Profit margin | -49.4% |
Oper. margin | -5.11% |
Gross margin | 50.1% |
EBIT margin | -5.11% |
EBITDA margin | 2.65% |
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freeCLS Holdings USA stock price history
CLS Holdings USA stock forecast
CLS Holdings USA financial statements
May 2022 | 6.15M | -1.52M | -24.7% |
---|---|---|---|
Feb 2023 | 5.43M | -1.02M | -18.94% |
May 2023 | 5.57M | -3.53M | -63.4% |
Feb 2024 | 4.92M | -4.36M | -88.69% |
Nov 2022 | 15522794 | 24.01M | 154.72% |
---|---|---|---|
Feb 2023 | 14381700 | 23.90M | 166.23% |
May 2023 | 10070648 | 23.87M | 237.04% |
Feb 2024 | 9130377 | 20.64M | 226.11% |
May 2022 | -600.32K | -977.94K | 675.54K |
---|---|---|---|
Feb 2023 | 802.72K | -57.18K | -666.32K |
May 2023 | 788.72K | -17.80K | -660.30K |
Feb 2024 | -415.78K | 11.76K | -656.77K |
CLS Holdings USA alternative data
Feb 2024 | 80 |
---|---|
Mar 2024 | 80 |
Apr 2024 | 80 |
May 2024 | 80 |
Jun 2024 | 80 |
Jul 2024 | 80 |
CLS Holdings USA other data
Period | Buy | Sel |
---|---|---|
Feb 2024 | 0 | 13628947 |
Quarter | Transcript |
---|---|
Q3 2022 14 Apr 2022 | Q3 2022 Earnings Call Transcript |
Insider | Compensation |
---|---|
Mr. Andrew J. Glashow (1963) Pres, Chief Operating Officer, Corporation Sec. & Director | $222,800 |
Mr. Jeffrey I. Binder (1947) Chairman & Chief Executive Officer | $200,000 |
-
What's the price of CLS Holdings USA stock today?
One share of CLS Holdings USA stock can currently be purchased for approximately $0.04.
-
When is CLS Holdings USA's next earnings date?
CLS Holdings USA, Inc. is estimated to report earnings on Wednesday, 27 Aug 2025.
-
Does CLS Holdings USA pay dividends?
No, CLS Holdings USA does not pay dividends.
-
How much money does CLS Holdings USA make?
CLS Holdings USA has a market capitalization of 4.55M and it's past years’ income statements indicate that its last revenue has decreased compared to the previous period by 13.71% to 19.96M US dollars.
-
What is CLS Holdings USA's stock symbol?
CLS Holdings USA, Inc. is traded on the OTC under the ticker symbol "CLSH".
-
What is CLS Holdings USA's primary industry?
Company operates in the Healthcare sector and Drug Manufacturers—Specialty & Generic industry.
-
How do i buy shares of CLS Holdings USA?
Shares of CLS Holdings USA can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
Who are CLS Holdings USA's key executives?
CLS Holdings USA's management team includes the following people:
- Mr. Andrew J. Glashow Pres, Chief Operating Officer, Corporation Sec. & Director(age: 62, pay: $222,800)
- Mr. Jeffrey I. Binder Chairman & Chief Executive Officer(age: 78, pay: $200,000)
-
When CLS Holdings USA went public?
CLS Holdings USA, Inc. is publicly traded company for more then 10 years since IPO on 23 Jun 2015.
-
What is CLS Holdings USA's official website?
The official website for CLS Holdings USA is clsholdingsinc.com.
-
Where are CLS Holdings USA's headquarters?
CLS Holdings USA is headquartered at 11767 South Dixie Highway, Miami, FL.
-
How can i contact CLS Holdings USA?
CLS Holdings USA's mailing address is 11767 South Dixie Highway, Miami, FL and company can be reached via phone at +888 4389132.
CLS Holdings USA company profile:

CLS Holdings USA, Inc.
clsholdingsinc.comOTC
0
Drug Manufacturers—Specialty & Generic
Healthcare
CLS Holdings USA, Inc., a diversified cannabis company, focuses on the extraction and conversion of cannabinoids in the United States. It extracts cannabinoids from the cannabis plants and converts into concentrates, such as oils, waxes, edibles, and shatters. The company also sells organic medical cannabis to licensed retailers; recreational marijuana cannabis products to licensed distributors and retailers; extraction products, such as oils and waxes derived from in-house cannabis production; and offers processing and extraction services for licensed medical cannabis cultivators, as well as cannabis strains in the form of vegetative cuttings to licensed medical cannabis cultivators. In addition, it provides consulting services to cannabis-related businesses comprising growers, dispensaries, and laboratories; and toll processing services. The company offers its products under Oasis Cannabis and City Trees brand names. Its concentrates are used for pharmaceutical and other purposes. CLS Holdings USA, Inc. was founded in 2014 and is based in Miami, Florida.
Miami, FL 33156
CIK: 0001522222
ISIN: US12565J1007
CUSIP: 12565J100